Pharmacokinetics and pharmacokinetic/pharmacodynamic modeling of filgotinib (GLPG0634), a selective JAK1 inhibitor, in support of Phase IIB dose selection - Namour, F; Diderichsen, P M; Cox, E (Clin Pharmacokinet, 2015)
et al.